About Applied BioCode
Applied BioCode is a company based in Santa Fe Springs (United States) founded in 2008. Applied BioCode has raised $20.29 million across 6 funding rounds from investors including NIH and HHS. Applied BioCode offers products and services including BioCode® MDx-3000, Gastrointestinal Pathogen Panel, Respiratory Pathogen Panel, BioCode® SARS-CoV-2 Assay, and BioCode® STI + Resistance Panel. Applied BioCode operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Santa Fe Springs, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Applied Biocode Corp.
-
Annual Revenue
$343.07 M-13.18as on Dec 31, 2024
-
Net Profit
-$260.81 M-58.84as on Dec 31, 2024
-
EBITDA
-$216.51 M-74.58as on Dec 31, 2024
-
Total Equity Funding
$20.29 M (USD)
in 6 rounds
-
Latest Funding Round
$9.26 M (USD), Series A
Apr 07, 2016
-
Investors
NIH
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Applied BioCode
Applied BioCode is a publicly listed company on the TWSE with ticker symbol 6598 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Applied BioCode
Applied BioCode offers a comprehensive portfolio of products and services, including BioCode® MDx-3000, Gastrointestinal Pathogen Panel, Respiratory Pathogen Panel, BioCode® SARS-CoV-2 Assay, and BioCode® STI + Resistance Panel.
High-throughput system for multiplex pathogen testing
Detects pathogens for gastroenteritis in clinical settings
Identifies common respiratory infection causes
Enables pooled testing for COVID-19 detection
Detects sexually transmitted infections and resistance
People of Applied BioCode
Unlock access to complete
Funding Insights of Applied BioCode
Applied BioCode has successfully raised a total of $20.29M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $9.26 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Applied BioCode
Applied BioCode has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Applied BioCode
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Applied BioCode
Investment portfolio details for Applied BioCode
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Applied BioCode
Detailed financials for Applied BioCode
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Applied Biocode Comparisons
Peer comparison for Applied BioCode
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Applied BioCode
Applied BioCode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Online platform offering life sciences reagents and kits
|
|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
Detailed competitors of Applied BioCode
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Applied Biocode
Complete news archive for Applied BioCode
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Applied BioCode
Applied BioCode was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Applied BioCode is headquartered in Santa Fe Springs, United States. It is registered at Santa Fe Springs, California, United States.
Applied BioCode is a funded company, having raised a total of $20.29M across 6 funding rounds to date.
Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The company develops, manufactures, and commercializes multiplex diagnostic testing products that inlcudes testing assays that detect pathogens for gastrointestinal infections, respiratory infections, and other high-value diseases. Also, it offers a BioCode MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP).
Applied BioCode's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Applied BioCode offers BioCode® MDx-3000, Gastrointestinal Pathogen Panel, Respiratory Pathogen Panel, BioCode® SARS-CoV-2 Assay, and BioCode® STI + Resistance Panel.
Yes, Applied BioCode is publicly traded on TWSE under the ticker symbol 6598.
The ticker symbol of Applied BioCode is 6598 on TWSE.